Inventage Labs, Inc. (CEO Joohee Kim), a drug delivery platform company, received the Minister of Health and Welfare Award (Institution) for its contribution to the commercialization of healthcare technologies at the "2025 Healthcare Industry Achievement Exchange" held on the 27th. This award was given based on its contribution to strengthening the competitiveness of the domestic biohealth industry through the development of long-acting injectables and mRNA therapeutic production technology.
Inventage Labs has developed a long-acting injectable technology, using its IVL-DrugFluidic® platform, that helps ensure a consistent drug release within the body. This technology allows the drug to remain effective for anywhere from one month to up to a year, enhancing patient convenience. Building on this technology, the company has achieved numerous achievements, including collaborations with global pharmaceutical companies, clinical trials, technology transfers, CMO partnerships, and a KOSDAQ listing. The company is also engaged in social contribution activities to develop treatments for opioid and alcohol dependence.
In addition, Inventage Labs has independently developed LNP (lipid nanoparticle) manufacturing technology, essential for the development of mRNA vaccines and gene therapies. HANDYGENE™, an automated equipment based on the IVL-GeneFluidic® platform, provides consistent particle quality and a stable production process, establishing a domestic LNP production base capable of automation and continuous production.
This Minister's Award is the culmination of two consecutive years of recognition for Inventage Lab's technological prowess and innovation. CEO Kim Joo-hee previously received the Prime Minister's Award and the Pharmaceutical Society of Korea Technology Award, while CTO Jeon Chan-hee received the Presidential Award. CEO Kim stated, "This Minister's Award is national recognition for our R&D, commercialization, and social contributions. We will make 2026 the first year of our global commercialization and grow into a competitive company in the global market."
- See more related articles
You must be logged in to post a comment.